News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
841,628 Results
Type
Article (86239)
Company Profile (651)
Press Release (754738)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232354)
Career Advice (4126)
Deals (39714)
Drug Delivery (127)
Drug Development (90845)
Employer Resources (198)
FDA (18043)
Job Trends (17330)
News (395842)
Policy (39707)
Tag
Academia (2995)
Academic (1)
Accelerated approval (6)
Adcomms (27)
Allergies (88)
Alliances (56738)
ALS (94)
Alzheimer's disease (1476)
Antibody-drug conjugate (ADC) (144)
Approvals (18033)
Artificial intelligence (251)
Autoimmune disease (27)
Automation (12)
Bankruptcy (404)
Best Places to Work (12564)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (448)
Bladder cancer (77)
Brain cancer (29)
Breast cancer (256)
Cancer (2169)
Cardiovascular disease (157)
Career advice (3533)
Career pathing (34)
CAR-T (163)
Cell therapy (455)
Cervical cancer (18)
Clinical research (73062)
Collaboration (833)
Company closure (1)
Compensation (496)
Complete response letters (30)
COVID-19 (2840)
CRISPR (46)
C-suite (238)
Cystic fibrosis (99)
Data (2036)
Decentralized trials (2)
Denatured (45)
Depression (41)
Diabetes (223)
Diagnostics (6787)
Digital health (9)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (126)
Drug pricing (111)
Drug shortages (22)
Duchenne muscular dystrophy (97)
Earnings (95841)
Editorial (42)
Employer branding (25)
Employer resources (167)
Events (129031)
Executive appointments (682)
FDA (19141)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (692)
Gene editing (105)
Generative AI (23)
Gene therapy (329)
GLP-1 (768)
Government (5131)
Grass and pollen (5)
Guidances (55)
Healthcare (20777)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (137)
Indications (28)
Infectious disease (2966)
Inflammatory bowel disease (151)
Inflation Reduction Act (11)
Influenza (46)
Intellectual property (94)
Interviews (812)
IPO (17741)
IRA (47)
Job creations (5186)
Job search strategy (2861)
Kidney cancer (11)
Labor market (41)
Layoffs (549)
Leadership (23)
Legal (10077)
Liver cancer (73)
Lung cancer (313)
Lymphoma (148)
Machine learning (6)
Management (65)
Manufacturing (317)
MASH (72)
Medical device (14358)
Medtech (14363)
Mergers & acquisitions (22356)
Metabolic disorders (661)
Multiple sclerosis (81)
NASH (23)
Neurodegenerative disease (107)
Neuropsychiatric disorders (27)
Neuroscience (2028)
NextGen: Class of 2025 (7667)
Non-profit (5065)
Now hiring (40)
Obesity (354)
Opinion (273)
Ovarian cancer (72)
Pain (85)
Pancreatic cancer (65)
Parkinson's disease (145)
Partnered (20)
Patents (224)
Patient recruitment (103)
Peanut (48)
People (65054)
Pharmaceutical (134)
Pharmacy benefit managers (17)
Phase I (22565)
Phase II (31756)
Phase III (23894)
Pipeline (1145)
Policy (158)
Postmarket research (3544)
Preclinical (10179)
Press Release (72)
Prostate cancer (105)
Psychedelics (35)
Radiopharmaceuticals (258)
Rare diseases (398)
Real estate (7386)
Recruiting (75)
Regulatory (26606)
Reports (56)
Research institute (2647)
Resumes & cover letters (649)
Rett syndrome (3)
RNA editing (5)
RSV (36)
Schizophrenia (73)
Series A (127)
Series B (76)
Service/supplier (25)
Sickle cell disease (52)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4288)
State (2)
Stomach cancer (11)
Supply chain (62)
Tariffs (46)
The Weekly (82)
Vaccines (755)
Venture capitalists (42)
Weight loss (249)
Women's health (37)
Worklife (20)
Date
Today (4)
Last 7 days (809)
Last 30 days (2301)
Last 365 days (30993)
2025 (9910)
2024 (35396)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1269)
Alabama (57)
Alaska (6)
Arizona (246)
Arkansas (9)
Asia (49976)
Australia (8815)
California (5663)
Canada (1872)
China (525)
Colorado (200)
Connecticut (237)
Delaware (137)
Europe (114482)
Florida (779)
Georgia (165)
Hawaii (1)
Idaho (64)
Illinois (541)
India (27)
Indiana (281)
Iowa (11)
Japan (154)
Kansas (111)
Kentucky (21)
Louisiana (12)
Maine (58)
Maryland (898)
Massachusetts (4439)
Michigan (194)
Minnesota (329)
Mississippi (1)
Missouri (64)
Montana (25)
Nebraska (26)
Nevada (57)
New Hampshire (52)
New Jersey (1693)
New Mexico (29)
New York (1600)
North Carolina (1059)
North Dakota (9)
Northern California (2433)
Ohio (174)
Oklahoma (13)
Oregon (45)
Pennsylvania (1275)
Puerto Rico (13)
Rhode Island (28)
South America (1651)
South Carolina (6)
South Dakota (1)
Southern California (2142)
Tennessee (59)
Texas (781)
United States (21639)
Utah (118)
Virginia (146)
Washington D.C. (56)
Washington State (547)
West Virginia (2)
Wisconsin (48)
841,628 Results for "sk bio pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital
February 24, 2025
·
11 min read
Press Releases
SK bioscience Expands Influenza Vaccine Exports to Southern Hemisphere Market
March 12, 2025
·
3 min read
Press Releases
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
February 25, 2025
·
5 min read
Press Releases
SK Life Science Labs Announces the Publication in Nature Communications of its Breakthrough Research on Molecular Glue Discovery to Advance Cancer Immunotherapy
May 2, 2025
·
4 min read
Mergers & acquisitions
Bluebird’s Second Suitor, Ayrmid, Fails To Produce an Offer
Despite making an unsolicited bid for gene therapy maker bluebird bio, Ayrmid failed to deliver a binding offer after weeks of due diligence. Bluebird’s board recommended that it go with Carlyle and SK Capital Partner’s original offer to take the company private for $30 million.
April 16, 2025
·
1 min read
·
Dan Samorodnitsky
Immunology and inflammation
Hillstar Bio Nets $67M Series A to Advance Autoimmune and Arthritis Pipeline
Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.
March 25, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
SK pharmteco Embarks on Journey to Achieve My Green Lab Certification, Solidifying Commitment to Sustainable Laboratory Practices
March 13, 2025
·
3 min read
Press Releases
Late-Breaking Research from SK Life Science Labs at AACR Annual Meeting Shows p300-Selective Degraders are Potent Growth Inhibitors in Models of Aggressive Prostate Cancers and Solid Tumors
April 29, 2025
·
4 min read
Mergers & acquisitions
Bluebird, Facing Cash Crunch, To Go Private In Deal Valued at $30M
The proposed acquisition by global investment firms Carlyle and SK Capital Partners could net shareholders $3 per share plus potential CVR dollars and provide bluebird bio with primary capital to expand the commercial reach of its gene therapies.
February 21, 2025
·
3 min read
·
Heather McKenzie
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
1 of 84,163
Next
